HLS Therapeutics : Reports Annual Meeting Results

HLS Therapeutics Inc. ('HLS' or the 'Company') (TSX: HLS), a pharmaceutical company focused on central nervous system and cardiovascular markets, announces voting results from its Annual Meeting of Shareholders held in a virtual format on June 18, 2021.

ABOUT HLS THERAPEUTICS INC.

Formed in 2015, HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

Contact:

Dave Mason

Tel: [phone]

Email: [e-mail]

(C) 2021 Electronic News Publishing, source ENP Newswire